Bioviratech

Bioviratech

ICO Ended
2,626 Views
Bioviratech combines the world of the pharmaceutical distribution of vaccines, international law, smart contracts/ Crypto and blockchain to generate legal contracts linked to unique smart contracts. These create tokenised options that give the bearer the right to, but not the cost of, a vaccine for a future pandemic after the most vulnerable have been vaccinated.
3.0
TOTAL SCORE
5.4
ICO PROFILE

(weight: 45%)

1
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
White paper: Read
ICO Time: 26 Sept 2022 - 25 Oct 2022
Token info
Ticker: BVT
Platform: Binance Chain
Financial
Accepting: BNB, ETH, USDT, Mastercard, VISA
Soft cap: 120,000 BVT
Hard cap: 360,000 BVT
HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Upcoming
Pharmeum
Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.
Upcoming
Hoard
Hoard is about to change the future of the video gaming industry by facilitating True Ownership of game assets on the blockchain. Today more and more people are selling virtual goods and services. With Hoard, all of this can be tokenized and made tradeable in a manner that is honest for all participants. We believe that Hoard will facilitate the global revolution in the Gaming Industry. Hoard offers a unique value-proposition to game makers and gamers alike; enabling real-world economies in games with true-ownership of virtual items, game-interoperability and new models of financing for the development of games.
Upcoming
Feniks
Feniks.Finance is a new financial blockchain based system, created on a fundamentally new concept, capable of scaling its speed as needed and adding new functionality. Feniks.Finance can be used as an international banking system for information transfer and payment execution. The first version of Feniks.Finance will be able to handle payments and storage of users' funds. Namely, the banking transactions labeled in the SWIFT system with MT103 as payment sent and MT202 as a receipt and crediting of the payment to the account. The next step in the development of the system will be a 700 group of SWIFT operations, namely documentary transactions better known as guarantees and letters of credit. The introduction of the 500 group, that is, the operation with securities, suggests that an exchange will appear in our network.
Upcoming
Safein
Safein is a blockchain-based single sign-on identity management platform ensuring security, comfort and trust for our customers. With Safein, users can easily demonstrate their true identity online where needed and control the extent of their personal data given out to various service providers.
Upcoming
Earth Token
The Natural Asset Exchange blockchain platform and Earth Token cryptocurrency initial coin offering (ICO) token sale provides a unique opportunity to truly transform the Natural Capital Asset market, by creating a Natural Asset Marketplace that allows all stakeholders in the climate value chain to participate.
Upcoming
MediLOT
MediLOT is a health data protocol that aims to solve the concerns of Electronic Health Records (EHR). Current EHR systems are fragmented, centralised and lack patient ownership. Through a dual blockchain solution, MediLOT incorporates Artificial Intelligence capabilities onboard its control and data layers which allows the equitable sharing of health data. The MediLOT ecosystem will consist of patients, healthcare providers, researchers and commercial companies.